{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T22:52:36Z","timestamp":1686955956618},"reference-count":51,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","techvir.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Techniques in Vascular and Interventional Radiology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.tvir.2022.100842","type":"journal-article","created":{"date-parts":[[2022,6,5]],"date-time":"2022-06-05T13:33:21Z","timestamp":1654436001000},"page":"100842","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Anti-Restenotic Technologies in the SFA: Balloons and Stents"],"prefix":"10.1016","volume":"25","author":[{"given":"Brent R.","family":"Keate","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyle J.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tvir.2022.100842_bib0001","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.ahj.2012.12.002","article-title":"High mortality risks after major lower extremity amputation in Medicare patients with peripheral artery disease","volume":"165","author":"Jones","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.tvir.2022.100842_bib0002","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/j.tvir.2016.04.001","article-title":"Epidemiology of peripheral arterial disease and critical limb ischemia","volume":"19","author":"Anahita","year":"2016","journal-title":"Tech Vasc Interv Radiol"},{"key":"10.1016\/j.tvir.2022.100842_bib0003","first-page":"518","article-title":"Optical coherence tomography: guided therapy of in-stent restenosis for peripheral arterial disease","volume":"58","author":"Lichtenberg","year":"2017","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"10.1016\/j.tvir.2022.100842_bib0004","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1136\/heart.89.2.218","article-title":"In-stent stenosis: pathology and implications for the development of drug eluting stents","volume":"89","author":"Bennett","year":"2003","journal-title":"Heart"},{"key":"10.1016\/j.tvir.2022.100842_bib0005","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/cvr\/cvt115","article-title":"Biological responses in stented arteries","volume":"99","author":"Chaabane","year":"2013","journal-title":"Cardiovascular Research"},{"issue":"6","key":"10.1016\/j.tvir.2022.100842_bib0006","article-title":"Angioplasty versus bare metal stenting for superficial femoral artery lesions","author":"Chowdhury","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.tvir.2022.100842_bib0007","doi-asserted-by":"crossref","first-page":"9552","DOI":"10.1073\/pnas.90.20.9552","article-title":"Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations","volume":"90","author":"Jordan","year":"1993","journal-title":"PNAS"},{"key":"10.1016\/j.tvir.2022.100842_bib0008","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1161\/01.ATV.20.5.1177","article-title":"Natural history and histological classification of atherosclerotic lesions: an update","volume":"20","author":"Stary","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.tvir.2022.100842_bib0009","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1161\/01.ATV.15.9.1512","article-title":"A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association","volume":"15","author":"Stary","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.tvir.2022.100842_bib0010","first-page":"79","article-title":"Human atherosclerosis. I. Cell constitution and characteristics of advanced lesions of the superficial femoral artery","volume":"114","author":"Ross","year":"1984","journal-title":"Am J Pathol"},{"key":"10.1016\/j.tvir.2022.100842_bib0011","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1161\/STROKEAHA.107.486480","article-title":"Artery-related differences in atherosclerosis expression: implications for atherogenesis and dynamics in intima-media thickness","volume":"38","author":"Dalager","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.tvir.2022.100842_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.carpath.2019.06.003","article-title":"Histological features of restenosis associated with paclitaxel drug-coated balloon: implications for therapy","volume":"43","author":"Krishnan","year":"2019","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.tvir.2022.100842_bib0013","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1161\/CIRCULATIONAHA.115.016900","article-title":"Durable clinical effectiveness with paclitaxel-eluting stents in the femoropopliteal artery: 5-year results of the Zilver PTX randomized trial","volume":"133","author":"Dake","year":"2016","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.tvir.2022.100842_bib0014","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1055\/s-0038-1676360","article-title":"Drug-eluting balloons and drug-eluting stents in the treatment of peripheral vascular disease","volume":"35","author":"Lindquist","year":"2018","journal-title":"Semin Intervent Radiol"},{"key":"10.1016\/j.tvir.2022.100842_bib0015","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1007\/s00270-017-1771-5","article-title":"Long-term results from the MAJESTIC trial of the Eluvia paclitaxel-eluting stent for femoropopliteal treatment: 3-year follow-up","volume":"40","author":"Muller-Hulsbeck","year":"2017","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"5","key":"10.1016\/j.tvir.2022.100842_bib0016","doi-asserted-by":"crossref","first-page":"e004450","DOI":"10.1161\/CIRCINTERVENTIONS.116.004450","article-title":"Impact of fluoropolymer-based paclitaxel delivery on neointimal proliferation and vascular healing: a comparative peripheral drug-eluting stent study in the familial hypercholesterolemic swine model of femoral restenosis","volume":"10","author":"Gasior","year":"2017","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.tvir.2022.100842_bib0017","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0140-6736(18)32262-1","article-title":"A polymer-coated, paclitaxel-eluting stent (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL): a randomised, non-inferiority trial","volume":"392","author":"Gray","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.tvir.2022.100842_bib0018","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jcin.2013.05.022","article-title":"The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty","volume":"7","author":"Scheinert","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.tvir.2022.100842_bib0019","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa1406235","article-title":"Trial of a paclitaxel-coated balloon for femoropopliteal artery disease","volume":"373","author":"Rosenfield","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tvir.2022.100842_bib0020","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.jcin.2017.04.041","article-title":"The 24-month results of the Lutonix global SFA registry: worldwide experience with Lutonix drug-coated balloon","volume":"10","author":"Thieme","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.tvir.2022.100842_bib0021","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/CIRCULATIONAHA.114.011004","article-title":"Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial","volume":"131","author":"Tepe","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.tvir.2022.100842_bib0022","article-title":"Treatment effect of drug-coated balloons is durable to 3 years in the femoropopliteal arteries: Long-term results of the IN.PACT SFA randomized trial","volume":"11","author":"Schneider","year":"2018","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.tvir.2022.100842_bib0023","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.118.007702","article-title":"Long-term clinical effectiveness of a drug-coated balloon for the treatment of femoropopliteal lesions: Five-year outcomes from the IN.PACT SFA randomized trial","volume":"12","author":"Laird","year":"2019","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.tvir.2022.100842_bib0024","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1161\/CIRCULATIONAHA.116.026493","volume":"135","author":"Schroeder","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.tvir.2022.100842_bib0025","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1161\/CIRCULATIONAHA.117.028893","article-title":"Stellarex drug-coated balloon for treatment of femoropopliteal disease: twelve-month outcomes from the randomized ILLUMENATE pivotal and pharmacokinetic studies","volume":"136","author":"Krishnan","year":"2017","journal-title":"Circulation."},{"key":"10.1016\/j.tvir.2022.100842_bib0026","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1016\/j.jcin.2018.08.034","article-title":"Sustainable antirestenosis effect with a low-dose drug-coated balloon: the ILLUMENATE European randomized clinical trial 2-year results","volume":"11","author":"Brodmann","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.tvir.2022.100842_bib0027","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1161\/CIRCULATIONAHA.119.040518","article-title":"Mortality assessment of paclitaxel-coated balloons: patient-level meta-analysis of the ILLUMENATE clinical program at 3 years","volume":"140","author":"Gray","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.tvir.2022.100842_bib0028","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jcin.2019.12.028","article-title":"A polymer-free paclitaxel-eluting stent versus a bare-metal stent for de novo femoropopliteal lesions: The BATTLE trial","volume":"13","author":"Gou\u00ebffic","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.tvir.2022.100842_bib0029","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1007\/s00270-017-1649-6","article-title":"Debulking atherectomy in the peripheral arteries: is there a role and what is the evidence?","volume":"40","author":"Katsanos","year":"2017","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.tvir.2022.100842_bib0030","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.jvs.2013.02.019","article-title":"Drug-coated balloon angioplasty after directional atherectomy improves outcome in restenotic femoropopliteal arteries","volume":"58","author":"Sixt","year":"2013","journal-title":"J Vasc Surg"},{"issue":"9","key":"10.1016\/j.tvir.2022.100842_bib0031","doi-asserted-by":"crossref","first-page":"e004848","DOI":"10.1161\/CIRCINTERVENTIONS.116.004848","article-title":"Directional atherectomy followed by a paclitaxel-coated balloon to inhibit restenosis and maintain vessel patency: twelve-month results of the DEFINITIVE AR study","volume":"10","author":"Zeller","year":"2017","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.tvir.2022.100842_bib0032","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011245","article-title":"Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta-analysis of randomized controlled trials","volume":"7","author":"Katsanos","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.tvir.2022.100842_bib0033","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012524","article-title":"Is there a real association between paclitaxel devices and mortality? Time to pause and re-evaluate what we know about this statistical finding","volume":"8","author":"Shishehbor","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.tvir.2022.100842_bib0034","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s00270-019-02324-4","article-title":"Paclitaxel-coated zilver ptx drug-eluting stent treatment does not result in increased long-term all-cause mortality compared to uncoated devices","volume":"43","author":"Dake","year":"2020","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.tvir.2022.100842_bib0035","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1001\/jamacardio.2019.0325","article-title":"Association of survival with femoropopliteal artery revascularization with drug-coated devices","volume":"4","author":"Secemsky","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.tvir.2022.100842_bib0036","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1016\/j.jacc.2019.02.020","article-title":"Drug-eluting stent implantation and long-term survival following peripheral artery revascularization","volume":"73","author":"Secemsky","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"23","key":"10.1016\/j.tvir.2022.100842_bib0037","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1161\/CIRCULATIONAHA.119.044697","article-title":"Mortality and paclitaxel-coated devices: an individual patient data meta-analysis","volume":"141","author":"Rocha Singh","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.tvir.2022.100842_bib0038","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.jacc.2014.06.1198","article-title":"Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trial","volume":"64","author":"Zeller","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tvir.2022.100842_bib0039","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.jcin.2019.10.059","article-title":"The IN.PACT DEEP clinical drug-coated balloon trial: 5-year outcomes","volume":"13","author":"Zeller","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.tvir.2022.100842_bib0040","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004877","article-title":"Long-term follow-up of the PADI trial: percutaneous transluminal angioplasty versus drug-eluting stents for infrapopliteal lesions in critical limb ischemia","volume":"6","author":"Spreen","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"22","key":"10.1016\/j.tvir.2022.100842_bib0041","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1016\/j.jacc.2012.08.989","article-title":"A prospective randomized multicenter comparison of balloon angioplasty and infrapopliteal stenting with the sirolimus-eluting stent in patients with ischemic peripheral arterial disease: 1-year results from the ACHILLES trial","volume":"60","author":"Scheinert","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tvir.2022.100842_bib0042","first-page":"232","article-title":"Lutonix 014 DCB global below the knee registry study: interim 6-month outcomes","volume":"59","author":"Thieme","year":"2018","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"10.1016\/j.tvir.2022.100842_bib0043","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1177\/1526602816671740","volume":"23","author":"Katsanos","year":"2016","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.tvir.2022.100842_bib0044","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1177\/1538574416689426","article-title":"Systematic review and meta-analysis of drug-eluting balloon and stent for infrapopliteal artery revascularization","volume":"51","author":"Zhang","year":"2017","journal-title":"Vasc Endovascular Surg"},{"key":"10.1016\/j.tvir.2022.100842_bib0045","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1177\/1526602818799736","article-title":"Three-year results of the Absorb everolimus-eluting bioresorbable vascular scaffold in infrapopliteal arteries","volume":"25","author":"Varcoe","year":"2018","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.tvir.2022.100842_bib0046","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s11883-019-0816-4","article-title":"The current literature on bioabsorbable stents: a review","volume":"21","author":"Omar","year":"2019","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.tvir.2022.100842_bib0047","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1016\/j.jacc.2017.10.010","article-title":"3-year clinical outcomes with everolimus-eluting bioresorbable coronary scaffolds: the ABSORB III trial","volume":"70","author":"Kereiakes","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tvir.2022.100842_bib0048","doi-asserted-by":"crossref","first-page":"e1383","DOI":"10.4244\/EIJ-D-18-01058","article-title":"Twelve-month outcomes of 400 patients treated with a resorbable metal scaffold: insights from the BIOSOLVE-IV registry","volume":"15","author":"Verheye","year":"2020","journal-title":"EuroIntervention"},{"key":"10.1016\/j.tvir.2022.100842_bib0049","unstructured":"Abizaid A, Didier C, Frey N, et\u00a0al: 6-month clinical and angiographic outcomes of a novel radiopaque sirolimus-eluting bioresorbable vascular scaffold: the FANTOM II study."},{"key":"10.1016\/j.tvir.2022.100842_bib0050","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.avsg.2019.03.034","article-title":"Early-stage vascular response between bare metal stent and drug-free bioresorbable vascular scaffold in the small-sized peripheral artery: a preclinical study in porcine femoral arteries","volume":"60","author":"Ahn","year":"2019","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.tvir.2022.100842_bib0051","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ijcard.2018.11.113","article-title":"Comparison of the biodegradable polymer everolimus-eluting stent with contemporary drug-eluting stents: A systematic review and meta-analysis","volume":"278","author":"Picard","year":"2019","journal-title":"Int J Cardiol"}],"container-title":["Techniques in Vascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089251622000476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089251622000476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T21:37:27Z","timestamp":1679953047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089251622000476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S1089251622000476"],"URL":"https:\/\/doi.org\/10.1016\/j.tvir.2022.100842","relation":{},"ISSN":["1089-2516"],"issn-type":[{"value":"1089-2516","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-Restenotic Technologies in the SFA: Balloons and Stents","name":"articletitle","label":"Article Title"},{"value":"Techniques in Vascular and Interventional Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tvir.2022.100842","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100842"}}